View : 397 Download: 0

Full metadata record

DC Field Value Language
dc.contributor.author김재상*
dc.date.accessioned2025-10-27T16:30:02Z-
dc.date.available2025-10-27T16:30:02Z-
dc.date.issued2025*
dc.identifier.issn0925-4439*
dc.identifier.otherOAK-37974*
dc.identifier.urihttps://dspace.ewha.ac.kr/handle/2015.oak/273143-
dc.description.abstractAccelerated cholesterol and lipid metabolism are hallmarks of non-small cell lung cancer (NSCLC). Recently, epidermal growth factor receptor (EGFR) signaling has been shown to regulate de novo cholesterol synthesis and low-density lipoprotein receptor (LDLR) expression through SREBP-1-dependent pathways. This suggests that targeting EGFR signaling in cholesterol metabolism might provide a new therapeutic strategy for NSCLC. In this study, we demonstrated that AX-0085, a small-molecule drug, significantly inhibits EGFR kinase activity and subsequently suppresses cholesterol and lipid metabolism in NSCLC. Transcriptomic analysis showed that cholesterol and lipid metabolism-related transcripts were significantly downregulated in AX-0085-treated NSCLC cells compared to the mock control. In addition, AX-0085 downregulates EGF signaling-dependent SREBP1-mediated cholesterol biosynthesis-related enzymes and LDLR in NSCLC. Moreover, AX-0085 dramatically reduced proliferation, colony-forming ability, and migration in NSCLC cells by blocking EGFR signaling. Furthermore, treatment with AX-0085 decreased both tumor size and volume in the LLC-xenograft model. These results demonstrate that AX-0085 effectively suppresses cholesterol metabolism in NSCLC cells by inhibiting EGF-mediated SREBP1 signaling, suggesting a potential therapeutic strategy targeting cholesterol metabolism in NSCLC. © 2025 Elsevier B.V.*
dc.description.sponsorshipElsevier B.V.*
dc.languageEnglish*
dc.subjectCholesterol biosynthesis*
dc.subjectEpidermal growth factor receptor*
dc.subjectKinase activity*
dc.subjectLipid uptake*
dc.subjectLow-density lipoprotein receptor*
dc.subjectNon-small cell lung cancer*
dc.subjectTumor growth*
dc.titleEGFR inhibitor suppresses tumor growth by blocking lipid uptake and cholesterol synthesis in non-small cell lung cancer*
dc.typeArticle*
dc.relation.issue7*
dc.relation.volume1871*
dc.relation.indexSCIE*
dc.relation.indexSCOPUS*
dc.relation.journaltitleBiochimica et Biophysica Acta - Molecular Basis of Disease*
dc.identifier.doi10.1016/j.bbadis.2025.167957*
dc.identifier.wosidWOS:001523312100001*
dc.identifier.scopusid2-s2.0-105008814558*
dc.author.googleRhie B.-H.*
dc.author.googleWoo S.H.*
dc.author.googleKim H.-Y.*
dc.author.googleKarapurkar J.K.*
dc.author.googleJo W.-J.*
dc.author.googleKim J.*
dc.author.googleKim D.H.*
dc.author.googleChoi M.J.*
dc.author.googlePark Y.J.*
dc.author.googleHong Y.*
dc.author.googleHong S.-H.*
dc.author.googleRamakrishna S.*
dc.author.googleKim K.-S.*
dc.contributor.scopusid김재상(8643335800)*
dc.date.modifydate20260618111230*
Appears in Collections:
자연과학대학 > 생명과학전공 > Journal papers
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML


qrcode

BROWSE